Thoracic cancer surgery during the COVID-19 pandemic: a consensus statement from the Thoracic Domain of the Asian Society for Cardiovascular and Thoracic Surgery.
Sanghoon JheonAneez Db AhmedVincent Wt FangWoohyun JungAli Zamir KhanJang-Ming LeeAlan Dl SihoePunnarerk ThongcharoenMasahiro TsuboiAkif TurnaJun NakajimaPublished in: Asian cardiovascular & thoracic annals (2020)
Services for patients with thoracic cancer should be maintained during the COVID-19 pandemic. The position of the Society is that thoracic surgeons have a responsibility to perform good surgical management of thoracic cancer during the pandemic, to advocate for patients' rights to receive it, and to safeguard patients and staff from infection.
Keyphrases
- spinal cord
- end stage renal disease
- papillary thyroid
- newly diagnosed
- ejection fraction
- chronic kidney disease
- thoracic surgery
- squamous cell
- primary care
- prognostic factors
- sars cov
- squamous cell carcinoma
- coronavirus disease
- coronary artery disease
- acute coronary syndrome
- childhood cancer
- coronary artery bypass
- patient reported
- percutaneous coronary intervention
- health insurance